期刊文献+

头孢地尼与头孢特仑对照治疗急性泌尿系统细菌感染26例 被引量:3

Comparison of the efficacy of cefdinir and cefteram in treatment of acute bacterial urinary tract infections
下载PDF
导出
摘要 目的:评价头孢地尼治疗急性泌尿系统细菌性感染的安全性和有效性。方法:采用随机、单盲及平行对照法,26例轻、中度急性肾盂肾炎和急性膀胱炎患者随机均分为试验组和对照组,试验组服用头孢地尼胶囊,对照组服用头孢特仑片,剂量均为100mg,tid,疗程7d。结果:试验组与对照组细菌清除率均为100.0%,痊愈率均为76.9%,总有效率分别为100.0%和92.3%,疗效差异无显著性。头孢地尼抗菌活性与头孢特仑相似(P>0.05),而优于头孢克肟、阿莫西林+克拉维酸(P<0.05)。2组不良事件发生率均为7.7%,差异没有显著性(P>0.05)。结论:头孢地尼治疗敏感菌所致急性泌尿系统的轻、中度感染安全有效。 Objective:To compare the efficacy and safety of cefdinir and cefteram in treatment of acute bacterial urinary tract infections. Methods: 26 patients with mild to moderate acute pyelonephritis or acute cystitis were randomly and equally divided to receive cefdinir or cefteram, in a dose of 100mg 3 times daily for 7d in both groups. Results:The bacterial eradication rate was 100.0% for both groups,the cure rate was 76.9% for both groups,and the total effective rate was 100.0% for cefdinir group and 92.3% for cefteram group. The incidence of ADRs was 7.7% for both groups. No significant difference was observed in all the parameters between groups. Conclusion: Cefdinir is safe and effective in treatment of mild to moderate acute bacterial urinary infections caused by bacteria sensitive to cefdinir.
出处 《中国新药杂志》 CAS CSCD 北大核心 2004年第4期351-353,共3页 Chinese Journal of New Drugs
关键词 头孢地尼 头孢特仑 急性泌尿系统细菌感染 cefdinir cefteram acute bacterial urinary tract infections
  • 相关文献

参考文献6

  • 1Guay DR.Cefdinir: an advanced-generation,broad-spectrum oral cephalosporin[J]. Clin Ther ,2002,24(4) :473 - 489.
  • 2Guay DR. Novel oral cephalosporins[J]. Expert Opin Investig Drugs ,2000,9(2): 237 - 246.
  • 3Watanabe Y,Hatano K,Matsumoto Y,et al. In vitro antibacterial activity of FK041, a new orally active cephalosporin [J]. J Antibiot(Tokyo), 1999,52(7) :649 - 659.
  • 4Wise R, Andrews JM, Thornber D. The in vitro activity of cefdinir ( FK482 ), a new oral cephalosporin [J]. J Antimicrob Chemother, 1991,28(2): 239 - 248.
  • 5Nagate T,Akashi T, Numata K, et al. In vitro and in vivo antibacterial activity and pharmacokinetics of SC-002 and its derivative, SC-004: new oral cephalosporins [J]. Chemotherapy, 2001,47(3): 157 - 169.
  • 6Leigh AP,Nemeth MA,Keyserling CH,et al. Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection [J]. Clin Ther ,2000,22(7) :818 - 825.

同被引文献35

  • 1张明发,辛海涛.头孢地尼的临床应用评价[J].中国医院用药评价与分析,2004,4(5):269-273. 被引量:13
  • 2许亚红,向承发.头孢地尼颗粒治疗小儿急性化脓性扁桃体炎38例体会[J].西南国防医药,2005,15(4):387-388. 被引量:1
  • 3李健华,顾学兰,邹建军.头孢特仑酯药物动力学及生物利用度研究[J].中南药学,2006,4(2):115-118. 被引量:6
  • 4刘玉华,侯安存,许淑珍,张淑兰,王建成,陈莉,张忠浩.头孢地尼颗粒剂治疗儿童急性细菌性扁桃体炎的疗效和安全性[J].中国新药杂志,2006,15(17):1478-1480. 被引量:5
  • 5Pichichero ME, Doern GV, Kuti JL, et al. Probability of achieving requisite pharmacodynamic exposure for oral beta - lactam regimens against Haemophilus influenzae in children[J]. Paediatr Drugs, 2008,10 (6) : 391.
  • 6Brook Itzhak, MD, MSc.A pooled comparison of cefdinir and penicillin in the treatment of group a beta-hemolytic streptococcal pharyngotonsillitis[J].Clin Ther, 2005, 27 (8) : 1 266.
  • 7Guay DRP. Cefdinir: An advanced-generation, braod-spectrum oral cephalosporin[J].Clin Ther, 2002,24(4) : 473.
  • 8Block SL, Cifaldi M, Gu Y, et al. A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: a multicenter, prospective, singleblind study[J]. Clin Ther, 2005,27(6) : 786.
  • 9Henry DC, Kapral D, Busman TA, et al.Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study[J].Clin Ther, 2004,26 ( 12 ) : 2 026.
  • 10Steurer M, Schenk EEfficacy and safety of cefdinir in the treatment of maxillary sinusitis[J].Eur Arch Otorhinolaryngol,2000,257 (3) : 140.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部